Analysts have set 12-month price targets for CME Group, revealing an average target of $266.18, a high estimate of $305.00, ...

Momentum investing revolves around the idea of following a stock's recent trend in either direction. In the 'long' context, investors will be essentially be "buying high, but hoping to sell even ...

Analysts have provided CME Gr with 12 ratings, resulting in a consensus rating of Neutral. The average one-year price target ...

CME Group's first-quarter earnings fell short due to rising operational expenses, mainly from technology investments, despite ...

Shares of CME Group Inc. Cl A CME shed 1.54% to $261.48 Wednesday, on what proved to be an all-around great trading session ...

CME Group Inc. Cl A closed 2.87% below its 52-week high of $273.42, which the company reached on April 4th.

Other equities research analysts have also issued research reports about the stock. Oppenheimer raised their target price on shares of CME Group from $258.00 to $269.00 and gave the stock an ...

CME Group, a Zacks Rank #1 (Strong Buy), is the world’s leading and most diverse derivatives marketplace. CME Group operates contract markets for the trading of futures and options worldwide.

With an ROA of 0.64%, the company may face hurdles in achieving optimal financial performance. Debt Management: CME Group's debt-to ... Analysts typically rate each stock once per quarter.

JPMorgan Chase & Co. raised their price objective on shares of CME Group from $209.00 to $212.00 and gave the stock an “underweight” rating in a report on Thursday, February 13th. Royal Bank o ...